Related Experiment Videos

Hyperhomocysteinemia in patients with coronary artery disease

N Mahanonda1, W Leowatana, K Bhuripanyo

  • 1Her Majesty Cardiac Center, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Insights

Hyperhomocysteinemia, a condition of high homocysteine levels, is a significant risk factor for coronary artery disease. A total homocysteine (tHcy) level of 11.0 mmol/L best predicts this cardiovascular risk.

Area of Science:

  • Cardiovascular Medicine
  • Metabolic Disorders
  • Atherosclerosis Research

Background:

  • Hyperhomocysteinemia is an established risk factor for atherosclerosis.
  • Understanding the specific risk of coronary artery disease (CAD) in patients with hyperhomocysteinemia is crucial for clinical practice.

Purpose of the Study:

  • To quantify the risk of coronary artery disease (CAD) associated with hyperhomocysteinemia.
  • To identify independent risk factors for CAD in this patient population.

Main Methods:

  • Retrospective analysis of patient data.
  • Statistical evaluation to determine independent risk factors for CAD.
  • Assessment of total homocysteine (tHcy) levels for predictive accuracy.

Main Results:

  • Age, HDL level, total homocysteine (tHcy) level, and a history of diabetes mellitus (DM) were identified as independent risk factors for CAD.
  • A tHcy level of 11.0 mmol/L demonstrated optimal sensitivity and specificity for predicting CAD.

Conclusions:

  • Elevated tHcy levels are a significant independent risk factor for CAD.
  • The threshold of 11.0 mmol/L for tHcy offers a valuable predictive marker for coronary artery disease.

Related Concept Videos